Perimenopause
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age in line with perimenopausal period (40-55 years old) women; 2. Meet the above diagnostic criteria of Chinese and Western medicine; 3. No organic disease uterus and bilateral ovaries intact; 4. Able to understand and cooperate with the completion of treatment evaluation and follow-up; 5. Agree and voluntarily participate in this study and sign informed consent in person.
Exclusion criteria
Exclusion criteria: 1. do not meet the above inclusion criteria; 2. known or suspected pregnancy; 3. unexplained vaginal bleeding: vaginal bleeding causes including neoplastic inflammatory iatrogenic traumatic and ovarian dysfunction; 4. known or suspected breast cancer. 5 Known or suspected sex hormone-dependent malignancy. 6 Active venous or arterial thromboembolic disease within the last 6 months. 7 Severe liver and kidney dysfunction. If repeated measurements of liver and kidney function are 2 to 3 times higher than normal values medical diagnosis and treatment are recommended first. (8) Patients with serious primary diseases such as cardiovascular lung liver kidney hematopoietic system and reproductive system; (9) Patients who have used hormone drugs psychotropic drugs and anticoagulant drugs in the past 1 month; (10) Patients who are conducting other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-rating Depression Scale;Menopause Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Menopause-specific Quality of Life;Self-rating Anxiety Scale;Serum Sex Hormones;Insomnia Severity Index;Traditional Chinese Medicine Syndrome Scoring Scale; | — |
Countries
China
Contacts
Shanghai TCM-Integrated Hospital Shanghai University of TCM